Article Details
Retrieved on: 2022-12-09 16:56:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The last available COVID-19 monoclonal antibody, bebtelovimab, is now no longer authorized due to suspected inability to neutralize the most ...
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here